Medium materiality5/10
Phathom Pharmaceuticals initiated with a Market Perform at Leerink
Why it may matterVerify against the original reporting
Small upside potential.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Small upside potential.
What happened, with direct paths to the underlying reporting
Leerink initiates Phathom with Market Perform; target $10 vs price $9.43.
Target: $10
Posted price: $9.43
Analyst firm: Leerink Partners
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.